REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 50 filers reported holding REGULUS THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $16,000 | -79.7% | 24,297 | -77.9% | 0.00% | – |
| Q1 2018 | $79,000 | -82.1% | 109,993 | -74.1% | 0.00% | -100.0% |
| Q4 2017 | $441,000 | -11.3% | 424,400 | +6.7% | 0.00% | 0.0% |
| Q3 2017 | $497,000 | +7.3% | 397,728 | -15.4% | 0.00% | 0.0% |
| Q2 2017 | $463,000 | -45.3% | 470,260 | +25.0% | 0.00% | -50.0% |
| Q4 2016 | $847,000 | +457.2% | 376,234 | +714.2% | 0.00% | – |
| Q3 2016 | $152,000 | -88.3% | 46,211 | -75.2% | 0.00% | -100.0% |
| Q1 2016 | $1,294,000 | +178.3% | 186,675 | +249.9% | 0.00% | +200.0% |
| Q4 2015 | $465,000 | +74.8% | 53,352 | +119.5% | 0.00% | 0.0% |
| Q2 2015 | $266,000 | -1.1% | 24,308 | +45.1% | 0.00% | 0.0% |
| Q4 2014 | $269,000 | -74.1% | 16,749 | -85.4% | 0.00% | -66.7% |
| Q1 2014 | $1,037,000 | -3.2% | 115,000 | -20.6% | 0.00% | 0.0% |
| Q4 2013 | $1,071,000 | -9.2% | 144,880 | +15.9% | 0.00% | -25.0% |
| Q3 2013 | $1,179,000 | – | 125,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,039,823 | $26,420,000 | 3.79% |
| Foresite Capital Management II, LLC | 1,750,269 | $11,447,000 | 3.48% |
| ARGONAUT CAPITAL MANAGEMENT CORP | 75,000 | $491,000 | 1.65% |
| Abingworth LLP | 327,350 | $2,138,000 | 1.25% |
| Trellus Management Company, LLC | 100,000 | $654,000 | 0.96% |
| Cormorant Asset Management, LP | 896,522 | $5,863,000 | 0.94% |
| DAFNA Capital Management LLC | 90,000 | $589,000 | 0.58% |
| ORACLE INVESTMENT MANAGEMENT INC | 749,064 | $4,898,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |